Driven By The Urgency Of Cancer Patients Who Need Effective Therapies
Our mission is to expand the reach of targeted oncology therapeutics by developing products that address areas of significant unmet need.
A Focused Pipeline Portfolio
By leveraging our deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, we have developed a pipeline of small molecule kinase inhibitor candidates for difficult-to-treat, genomically defined cancers.
